Global Cancer Recurrence Monitoring Kit Supply, Demand and Key Producers, 2023-2029
The global Cancer Recurrence Monitoring Kit market size is expected to reach $ 3347.5 million by 2029, rising at a market growth of 11.5% CAGR during the forecast period (2023-2029).
Cancer recurrence monitoring kit is one of the important products in the field of medical diagnosis and has a wide market demand. This market prospect continues to grow with increasing number of cancer patients and increasing pursuit of early diagnosis and treatment. The size and growth potential of the market may be affected by a variety of factors, including the increase in cancer patients, technological advancements, improvements in the healthcare system, etc.
The Cancer Recurrence Monitoring Kit is a medical diagnostic tool used to detect whether patients who have been diagnosed with cancer have experienced recurrence or progression of the cancer after treatment. These test kits are typically evaluated by detecting biomarkers or tumor markers in a patient's body fluids, such as blood, urine, or saliva. These markers are proteins, cells or genes associated with cancer, and their presence or changes in levels can indicate the recurrence of cancer.
This report studies the global Cancer Recurrence Monitoring Kit production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cancer Recurrence Monitoring Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Recurrence Monitoring Kit that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cancer Recurrence Monitoring Kit total production and demand, 2018-2029, (K Units)
Global Cancer Recurrence Monitoring Kit total production value, 2018-2029, (USD Million)
Global Cancer Recurrence Monitoring Kit production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cancer Recurrence Monitoring Kit domestic production, consumption, key domestic manufacturers and share
Global Cancer Recurrence Monitoring Kit production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Cancer Recurrence Monitoring Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SeekIn, Guardant Health, Neoimmune, Labcorp Inc, F.Hoffmann-La Roche Ltd., Cergentis B.V., Sysmex Corporation, NeoGenomics Laboratories, Inc. and Adaptive, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Recurrence Monitoring Kit market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cancer Recurrence Monitoring Kit Market, By Region:
1. How big is the global Cancer Recurrence Monitoring Kit market?
2. What is the demand of the global Cancer Recurrence Monitoring Kit market?
3. What is the year over year growth of the global Cancer Recurrence Monitoring Kit market?
4. What is the production and production value of the global Cancer Recurrence Monitoring Kit market?
5. Who are the key producers in the global Cancer Recurrence Monitoring Kit market?
Cancer recurrence monitoring kit is one of the important products in the field of medical diagnosis and has a wide market demand. This market prospect continues to grow with increasing number of cancer patients and increasing pursuit of early diagnosis and treatment. The size and growth potential of the market may be affected by a variety of factors, including the increase in cancer patients, technological advancements, improvements in the healthcare system, etc.
The Cancer Recurrence Monitoring Kit is a medical diagnostic tool used to detect whether patients who have been diagnosed with cancer have experienced recurrence or progression of the cancer after treatment. These test kits are typically evaluated by detecting biomarkers or tumor markers in a patient's body fluids, such as blood, urine, or saliva. These markers are proteins, cells or genes associated with cancer, and their presence or changes in levels can indicate the recurrence of cancer.
This report studies the global Cancer Recurrence Monitoring Kit production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cancer Recurrence Monitoring Kit, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Recurrence Monitoring Kit that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cancer Recurrence Monitoring Kit total production and demand, 2018-2029, (K Units)
Global Cancer Recurrence Monitoring Kit total production value, 2018-2029, (USD Million)
Global Cancer Recurrence Monitoring Kit production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Cancer Recurrence Monitoring Kit domestic production, consumption, key domestic manufacturers and share
Global Cancer Recurrence Monitoring Kit production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Cancer Recurrence Monitoring Kit production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Cancer Recurrence Monitoring Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SeekIn, Guardant Health, Neoimmune, Labcorp Inc, F.Hoffmann-La Roche Ltd., Cergentis B.V., Sysmex Corporation, NeoGenomics Laboratories, Inc. and Adaptive, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Recurrence Monitoring Kit market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cancer Recurrence Monitoring Kit Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood Cancer
- Bone Cancer
- Hospital
- Clinic
- SeekIn
- Guardant Health
- Neoimmune
- Labcorp Inc
- F.Hoffmann-La Roche Ltd.
- Cergentis B.V.
- Sysmex Corporation
- NeoGenomics Laboratories, Inc.
- Adaptive
- Biotechnologies Corporation
- ArcherDX, Inc.
- Asuragen Inc.
- Arup Laboratories Inc.
- Bio-Rad Laboratories
- Opko Health
- Quest Diagnostics
- ICON plc
1. How big is the global Cancer Recurrence Monitoring Kit market?
2. What is the demand of the global Cancer Recurrence Monitoring Kit market?
3. What is the year over year growth of the global Cancer Recurrence Monitoring Kit market?
4. What is the production and production value of the global Cancer Recurrence Monitoring Kit market?
5. Who are the key producers in the global Cancer Recurrence Monitoring Kit market?
1 SUPPLY SUMMARY
1.1 Cancer Recurrence Monitoring Kit Introduction
1.2 World Cancer Recurrence Monitoring Kit Supply & Forecast
1.2.1 World Cancer Recurrence Monitoring Kit Production Value (2018 & 2022 & 2029)
1.2.2 World Cancer Recurrence Monitoring Kit Production (2018-2029)
1.2.3 World Cancer Recurrence Monitoring Kit Pricing Trends (2018-2029)
1.3 World Cancer Recurrence Monitoring Kit Production by Region (Based on Production Site)
1.3.1 World Cancer Recurrence Monitoring Kit Production Value by Region (2018-2029)
1.3.2 World Cancer Recurrence Monitoring Kit Production by Region (2018-2029)
1.3.3 World Cancer Recurrence Monitoring Kit Average Price by Region (2018-2029)
1.3.4 North America Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.5 Europe Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.6 China Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.7 Japan Cancer Recurrence Monitoring Kit Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Recurrence Monitoring Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Recurrence Monitoring Kit Major Market Trends
2 DEMAND SUMMARY
2.1 World Cancer Recurrence Monitoring Kit Demand (2018-2029)
2.2 World Cancer Recurrence Monitoring Kit Consumption by Region
2.2.1 World Cancer Recurrence Monitoring Kit Consumption by Region (2018-2023)
2.2.2 World Cancer Recurrence Monitoring Kit Consumption Forecast by Region (2024-2029)
2.3 United States Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.4 China Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.5 Europe Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.6 Japan Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.7 South Korea Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.8 ASEAN Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.9 India Cancer Recurrence Monitoring Kit Consumption (2018-2029)
3 WORLD CANCER RECURRENCE MONITORING KIT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cancer Recurrence Monitoring Kit Production Value by Manufacturer (2018-2023)
3.2 World Cancer Recurrence Monitoring Kit Production by Manufacturer (2018-2023)
3.3 World Cancer Recurrence Monitoring Kit Average Price by Manufacturer (2018-2023)
3.4 Cancer Recurrence Monitoring Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cancer Recurrence Monitoring Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cancer Recurrence Monitoring Kit in 2022
3.5.3 Global Concentration Ratios (CR8) for Cancer Recurrence Monitoring Kit in 2022
3.6 Cancer Recurrence Monitoring Kit Market: Overall Company Footprint Analysis
3.6.1 Cancer Recurrence Monitoring Kit Market: Region Footprint
3.6.2 Cancer Recurrence Monitoring Kit Market: Company Product Type Footprint
3.6.3 Cancer Recurrence Monitoring Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cancer Recurrence Monitoring Kit Production Value Comparison
4.1.1 United States VS China: Cancer Recurrence Monitoring Kit Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cancer Recurrence Monitoring Kit Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cancer Recurrence Monitoring Kit Production Comparison
4.2.1 United States VS China: Cancer Recurrence Monitoring Kit Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cancer Recurrence Monitoring Kit Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cancer Recurrence Monitoring Kit Consumption Comparison
4.3.1 United States VS China: Cancer Recurrence Monitoring Kit Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cancer Recurrence Monitoring Kit Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
4.5 China Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share
4.5.1 China Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.5.3 China Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
4.6 Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cancer Recurrence Monitoring Kit Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Cancer
5.2.2 Bone Cancer
5.3 Market Segment by Type
5.3.1 World Cancer Recurrence Monitoring Kit Production by Type (2018-2029)
5.3.2 World Cancer Recurrence Monitoring Kit Production Value by Type (2018-2029)
5.3.3 World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cancer Recurrence Monitoring Kit Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Cancer Recurrence Monitoring Kit Production by Application (2018-2029)
6.3.2 World Cancer Recurrence Monitoring Kit Production Value by Application (2018-2029)
6.3.3 World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 SeekIn
7.1.1 SeekIn Details
7.1.2 SeekIn Major Business
7.1.3 SeekIn Cancer Recurrence Monitoring Kit Product and Services
7.1.4 SeekIn Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 SeekIn Recent Developments/Updates
7.1.6 SeekIn Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Cancer Recurrence Monitoring Kit Product and Services
7.2.4 Guardant Health Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Neoimmune
7.3.1 Neoimmune Details
7.3.2 Neoimmune Major Business
7.3.3 Neoimmune Cancer Recurrence Monitoring Kit Product and Services
7.3.4 Neoimmune Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Neoimmune Recent Developments/Updates
7.3.6 Neoimmune Competitive Strengths & Weaknesses
7.4 Labcorp Inc
7.4.1 Labcorp Inc Details
7.4.2 Labcorp Inc Major Business
7.4.3 Labcorp Inc Cancer Recurrence Monitoring Kit Product and Services
7.4.4 Labcorp Inc Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Labcorp Inc Recent Developments/Updates
7.4.6 Labcorp Inc Competitive Strengths & Weaknesses
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 F.Hoffmann-La Roche Ltd. Details
7.5.2 F.Hoffmann-La Roche Ltd. Major Business
7.5.3 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product and Services
7.5.4 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
7.5.6 F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.6 Cergentis B.V.
7.6.1 Cergentis B.V. Details
7.6.2 Cergentis B.V. Major Business
7.6.3 Cergentis B.V. Cancer Recurrence Monitoring Kit Product and Services
7.6.4 Cergentis B.V. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Cergentis B.V. Recent Developments/Updates
7.6.6 Cergentis B.V. Competitive Strengths & Weaknesses
7.7 Sysmex Corporation
7.7.1 Sysmex Corporation Details
7.7.2 Sysmex Corporation Major Business
7.7.3 Sysmex Corporation Cancer Recurrence Monitoring Kit Product and Services
7.7.4 Sysmex Corporation Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sysmex Corporation Recent Developments/Updates
7.7.6 Sysmex Corporation Competitive Strengths & Weaknesses
7.8 NeoGenomics Laboratories, Inc.
7.8.1 NeoGenomics Laboratories, Inc. Details
7.8.2 NeoGenomics Laboratories, Inc. Major Business
7.8.3 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product and Services
7.8.4 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
7.8.6 NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
7.9 Adaptive
7.9.1 Adaptive Details
7.9.2 Adaptive Major Business
7.9.3 Adaptive Cancer Recurrence Monitoring Kit Product and Services
7.9.4 Adaptive Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Adaptive Recent Developments/Updates
7.9.6 Adaptive Competitive Strengths & Weaknesses
7.10 Biotechnologies Corporation
7.10.1 Biotechnologies Corporation Details
7.10.2 Biotechnologies Corporation Major Business
7.10.3 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product and Services
7.10.4 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biotechnologies Corporation Recent Developments/Updates
7.10.6 Biotechnologies Corporation Competitive Strengths & Weaknesses
7.11 ArcherDX, Inc.
7.11.1 ArcherDX, Inc. Details
7.11.2 ArcherDX, Inc. Major Business
7.11.3 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product and Services
7.11.4 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 ArcherDX, Inc. Recent Developments/Updates
7.11.6 ArcherDX, Inc. Competitive Strengths & Weaknesses
7.12 Asuragen Inc.
7.12.1 Asuragen Inc. Details
7.12.2 Asuragen Inc. Major Business
7.12.3 Asuragen Inc. Cancer Recurrence Monitoring Kit Product and Services
7.12.4 Asuragen Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Asuragen Inc. Recent Developments/Updates
7.12.6 Asuragen Inc. Competitive Strengths & Weaknesses
7.13 Arup Laboratories Inc.
7.13.1 Arup Laboratories Inc. Details
7.13.2 Arup Laboratories Inc. Major Business
7.13.3 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product and Services
7.13.4 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Arup Laboratories Inc. Recent Developments/Updates
7.13.6 Arup Laboratories Inc. Competitive Strengths & Weaknesses
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Details
7.14.2 Bio-Rad Laboratories Major Business
7.14.3 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product and Services
7.14.4 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bio-Rad Laboratories Recent Developments/Updates
7.14.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.15 Opko Health
7.15.1 Opko Health Details
7.15.2 Opko Health Major Business
7.15.3 Opko Health Cancer Recurrence Monitoring Kit Product and Services
7.15.4 Opko Health Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Opko Health Recent Developments/Updates
7.15.6 Opko Health Competitive Strengths & Weaknesses
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Details
7.16.2 Quest Diagnostics Major Business
7.16.3 Quest Diagnostics Cancer Recurrence Monitoring Kit Product and Services
7.16.4 Quest Diagnostics Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Quest Diagnostics Recent Developments/Updates
7.16.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.17 ICON plc
7.17.1 ICON plc Details
7.17.2 ICON plc Major Business
7.17.3 ICON plc Cancer Recurrence Monitoring Kit Product and Services
7.17.4 ICON plc Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 ICON plc Recent Developments/Updates
7.17.6 ICON plc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cancer Recurrence Monitoring Kit Industry Chain
8.2 Cancer Recurrence Monitoring Kit Upstream Analysis
8.2.1 Cancer Recurrence Monitoring Kit Core Raw Materials
8.2.2 Main Manufacturers of Cancer Recurrence Monitoring Kit Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cancer Recurrence Monitoring Kit Production Mode
8.6 Cancer Recurrence Monitoring Kit Procurement Model
8.7 Cancer Recurrence Monitoring Kit Industry Sales Model and Sales Channels
8.7.1 Cancer Recurrence Monitoring Kit Sales Model
8.7.2 Cancer Recurrence Monitoring Kit Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cancer Recurrence Monitoring Kit Introduction
1.2 World Cancer Recurrence Monitoring Kit Supply & Forecast
1.2.1 World Cancer Recurrence Monitoring Kit Production Value (2018 & 2022 & 2029)
1.2.2 World Cancer Recurrence Monitoring Kit Production (2018-2029)
1.2.3 World Cancer Recurrence Monitoring Kit Pricing Trends (2018-2029)
1.3 World Cancer Recurrence Monitoring Kit Production by Region (Based on Production Site)
1.3.1 World Cancer Recurrence Monitoring Kit Production Value by Region (2018-2029)
1.3.2 World Cancer Recurrence Monitoring Kit Production by Region (2018-2029)
1.3.3 World Cancer Recurrence Monitoring Kit Average Price by Region (2018-2029)
1.3.4 North America Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.5 Europe Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.6 China Cancer Recurrence Monitoring Kit Production (2018-2029)
1.3.7 Japan Cancer Recurrence Monitoring Kit Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cancer Recurrence Monitoring Kit Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cancer Recurrence Monitoring Kit Major Market Trends
2 DEMAND SUMMARY
2.1 World Cancer Recurrence Monitoring Kit Demand (2018-2029)
2.2 World Cancer Recurrence Monitoring Kit Consumption by Region
2.2.1 World Cancer Recurrence Monitoring Kit Consumption by Region (2018-2023)
2.2.2 World Cancer Recurrence Monitoring Kit Consumption Forecast by Region (2024-2029)
2.3 United States Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.4 China Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.5 Europe Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.6 Japan Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.7 South Korea Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.8 ASEAN Cancer Recurrence Monitoring Kit Consumption (2018-2029)
2.9 India Cancer Recurrence Monitoring Kit Consumption (2018-2029)
3 WORLD CANCER RECURRENCE MONITORING KIT MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cancer Recurrence Monitoring Kit Production Value by Manufacturer (2018-2023)
3.2 World Cancer Recurrence Monitoring Kit Production by Manufacturer (2018-2023)
3.3 World Cancer Recurrence Monitoring Kit Average Price by Manufacturer (2018-2023)
3.4 Cancer Recurrence Monitoring Kit Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cancer Recurrence Monitoring Kit Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cancer Recurrence Monitoring Kit in 2022
3.5.3 Global Concentration Ratios (CR8) for Cancer Recurrence Monitoring Kit in 2022
3.6 Cancer Recurrence Monitoring Kit Market: Overall Company Footprint Analysis
3.6.1 Cancer Recurrence Monitoring Kit Market: Region Footprint
3.6.2 Cancer Recurrence Monitoring Kit Market: Company Product Type Footprint
3.6.3 Cancer Recurrence Monitoring Kit Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cancer Recurrence Monitoring Kit Production Value Comparison
4.1.1 United States VS China: Cancer Recurrence Monitoring Kit Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Cancer Recurrence Monitoring Kit Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Cancer Recurrence Monitoring Kit Production Comparison
4.2.1 United States VS China: Cancer Recurrence Monitoring Kit Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cancer Recurrence Monitoring Kit Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Cancer Recurrence Monitoring Kit Consumption Comparison
4.3.1 United States VS China: Cancer Recurrence Monitoring Kit Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Cancer Recurrence Monitoring Kit Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.4.3 United States Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
4.5 China Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share
4.5.1 China Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.5.3 China Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
4.6 Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cancer Recurrence Monitoring Kit Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Blood Cancer
5.2.2 Bone Cancer
5.3 Market Segment by Type
5.3.1 World Cancer Recurrence Monitoring Kit Production by Type (2018-2029)
5.3.2 World Cancer Recurrence Monitoring Kit Production Value by Type (2018-2029)
5.3.3 World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cancer Recurrence Monitoring Kit Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Cancer Recurrence Monitoring Kit Production by Application (2018-2029)
6.3.2 World Cancer Recurrence Monitoring Kit Production Value by Application (2018-2029)
6.3.3 World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 SeekIn
7.1.1 SeekIn Details
7.1.2 SeekIn Major Business
7.1.3 SeekIn Cancer Recurrence Monitoring Kit Product and Services
7.1.4 SeekIn Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 SeekIn Recent Developments/Updates
7.1.6 SeekIn Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Cancer Recurrence Monitoring Kit Product and Services
7.2.4 Guardant Health Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Neoimmune
7.3.1 Neoimmune Details
7.3.2 Neoimmune Major Business
7.3.3 Neoimmune Cancer Recurrence Monitoring Kit Product and Services
7.3.4 Neoimmune Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Neoimmune Recent Developments/Updates
7.3.6 Neoimmune Competitive Strengths & Weaknesses
7.4 Labcorp Inc
7.4.1 Labcorp Inc Details
7.4.2 Labcorp Inc Major Business
7.4.3 Labcorp Inc Cancer Recurrence Monitoring Kit Product and Services
7.4.4 Labcorp Inc Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Labcorp Inc Recent Developments/Updates
7.4.6 Labcorp Inc Competitive Strengths & Weaknesses
7.5 F.Hoffmann-La Roche Ltd.
7.5.1 F.Hoffmann-La Roche Ltd. Details
7.5.2 F.Hoffmann-La Roche Ltd. Major Business
7.5.3 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product and Services
7.5.4 F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
7.5.6 F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.6 Cergentis B.V.
7.6.1 Cergentis B.V. Details
7.6.2 Cergentis B.V. Major Business
7.6.3 Cergentis B.V. Cancer Recurrence Monitoring Kit Product and Services
7.6.4 Cergentis B.V. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Cergentis B.V. Recent Developments/Updates
7.6.6 Cergentis B.V. Competitive Strengths & Weaknesses
7.7 Sysmex Corporation
7.7.1 Sysmex Corporation Details
7.7.2 Sysmex Corporation Major Business
7.7.3 Sysmex Corporation Cancer Recurrence Monitoring Kit Product and Services
7.7.4 Sysmex Corporation Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Sysmex Corporation Recent Developments/Updates
7.7.6 Sysmex Corporation Competitive Strengths & Weaknesses
7.8 NeoGenomics Laboratories, Inc.
7.8.1 NeoGenomics Laboratories, Inc. Details
7.8.2 NeoGenomics Laboratories, Inc. Major Business
7.8.3 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product and Services
7.8.4 NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 NeoGenomics Laboratories, Inc. Recent Developments/Updates
7.8.6 NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
7.9 Adaptive
7.9.1 Adaptive Details
7.9.2 Adaptive Major Business
7.9.3 Adaptive Cancer Recurrence Monitoring Kit Product and Services
7.9.4 Adaptive Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Adaptive Recent Developments/Updates
7.9.6 Adaptive Competitive Strengths & Weaknesses
7.10 Biotechnologies Corporation
7.10.1 Biotechnologies Corporation Details
7.10.2 Biotechnologies Corporation Major Business
7.10.3 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product and Services
7.10.4 Biotechnologies Corporation Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Biotechnologies Corporation Recent Developments/Updates
7.10.6 Biotechnologies Corporation Competitive Strengths & Weaknesses
7.11 ArcherDX, Inc.
7.11.1 ArcherDX, Inc. Details
7.11.2 ArcherDX, Inc. Major Business
7.11.3 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product and Services
7.11.4 ArcherDX, Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 ArcherDX, Inc. Recent Developments/Updates
7.11.6 ArcherDX, Inc. Competitive Strengths & Weaknesses
7.12 Asuragen Inc.
7.12.1 Asuragen Inc. Details
7.12.2 Asuragen Inc. Major Business
7.12.3 Asuragen Inc. Cancer Recurrence Monitoring Kit Product and Services
7.12.4 Asuragen Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Asuragen Inc. Recent Developments/Updates
7.12.6 Asuragen Inc. Competitive Strengths & Weaknesses
7.13 Arup Laboratories Inc.
7.13.1 Arup Laboratories Inc. Details
7.13.2 Arup Laboratories Inc. Major Business
7.13.3 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product and Services
7.13.4 Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Arup Laboratories Inc. Recent Developments/Updates
7.13.6 Arup Laboratories Inc. Competitive Strengths & Weaknesses
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Details
7.14.2 Bio-Rad Laboratories Major Business
7.14.3 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product and Services
7.14.4 Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Bio-Rad Laboratories Recent Developments/Updates
7.14.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.15 Opko Health
7.15.1 Opko Health Details
7.15.2 Opko Health Major Business
7.15.3 Opko Health Cancer Recurrence Monitoring Kit Product and Services
7.15.4 Opko Health Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Opko Health Recent Developments/Updates
7.15.6 Opko Health Competitive Strengths & Weaknesses
7.16 Quest Diagnostics
7.16.1 Quest Diagnostics Details
7.16.2 Quest Diagnostics Major Business
7.16.3 Quest Diagnostics Cancer Recurrence Monitoring Kit Product and Services
7.16.4 Quest Diagnostics Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Quest Diagnostics Recent Developments/Updates
7.16.6 Quest Diagnostics Competitive Strengths & Weaknesses
7.17 ICON plc
7.17.1 ICON plc Details
7.17.2 ICON plc Major Business
7.17.3 ICON plc Cancer Recurrence Monitoring Kit Product and Services
7.17.4 ICON plc Cancer Recurrence Monitoring Kit Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 ICON plc Recent Developments/Updates
7.17.6 ICON plc Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cancer Recurrence Monitoring Kit Industry Chain
8.2 Cancer Recurrence Monitoring Kit Upstream Analysis
8.2.1 Cancer Recurrence Monitoring Kit Core Raw Materials
8.2.2 Main Manufacturers of Cancer Recurrence Monitoring Kit Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Cancer Recurrence Monitoring Kit Production Mode
8.6 Cancer Recurrence Monitoring Kit Procurement Model
8.7 Cancer Recurrence Monitoring Kit Industry Sales Model and Sales Channels
8.7.1 Cancer Recurrence Monitoring Kit Sales Model
8.7.2 Cancer Recurrence Monitoring Kit Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cancer Recurrence Monitoring Kit Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cancer Recurrence Monitoring Kit Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cancer Recurrence Monitoring Kit Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2018-2023)
Table 5. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2024-2029)
Table 6. World Cancer Recurrence Monitoring Kit Production by Region (2018-2023) & (K Units)
Table 7. World Cancer Recurrence Monitoring Kit Production by Region (2024-2029) & (K Units)
Table 8. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2018-2023)
Table 9. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2024-2029)
Table 10. World Cancer Recurrence Monitoring Kit Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cancer Recurrence Monitoring Kit Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cancer Recurrence Monitoring Kit Major Market Trends
Table 13. World Cancer Recurrence Monitoring Kit Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cancer Recurrence Monitoring Kit Consumption by Region (2018-2023) & (K Units)
Table 15. World Cancer Recurrence Monitoring Kit Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cancer Recurrence Monitoring Kit Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cancer Recurrence Monitoring Kit Producers in 2022
Table 18. World Cancer Recurrence Monitoring Kit Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cancer Recurrence Monitoring Kit Producers in 2022
Table 20. World Cancer Recurrence Monitoring Kit Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cancer Recurrence Monitoring Kit Company Evaluation Quadrant
Table 22. World Cancer Recurrence Monitoring Kit Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cancer Recurrence Monitoring Kit Production Site of Key Manufacturer
Table 24. Cancer Recurrence Monitoring Kit Market: Company Product Type Footprint
Table 25. Cancer Recurrence Monitoring Kit Market: Company Product Application Footprint
Table 26. Cancer Recurrence Monitoring Kit Competitive Factors
Table 27. Cancer Recurrence Monitoring Kit New Entrant and Capacity Expansion Plans
Table 28. Cancer Recurrence Monitoring Kit Mergers & Acquisitions Activity
Table 29. United States VS China Cancer Recurrence Monitoring Kit Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cancer Recurrence Monitoring Kit Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cancer Recurrence Monitoring Kit Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 37. China Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 42. Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 47. World Cancer Recurrence Monitoring Kit Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cancer Recurrence Monitoring Kit Production by Type (2018-2023) & (K Units)
Table 49. World Cancer Recurrence Monitoring Kit Production by Type (2024-2029) & (K Units)
Table 50. World Cancer Recurrence Monitoring Kit Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cancer Recurrence Monitoring Kit Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cancer Recurrence Monitoring Kit Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cancer Recurrence Monitoring Kit Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cancer Recurrence Monitoring Kit Production by Application (2018-2023) & (K Units)
Table 56. World Cancer Recurrence Monitoring Kit Production by Application (2024-2029) & (K Units)
Table 57. World Cancer Recurrence Monitoring Kit Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cancer Recurrence Monitoring Kit Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cancer Recurrence Monitoring Kit Average Price by Application (2024-2029) & (US$/Unit)
Table 61. SeekIn Basic Information, Manufacturing Base and Competitors
Table 62. SeekIn Major Business
Table 63. SeekIn Cancer Recurrence Monitoring Kit Product and Services
Table 64. SeekIn Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. SeekIn Recent Developments/Updates
Table 66. SeekIn Competitive Strengths & Weaknesses
Table 67. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 68. Guardant Health Major Business
Table 69. Guardant Health Cancer Recurrence Monitoring Kit Product and Services
Table 70. Guardant Health Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Guardant Health Recent Developments/Updates
Table 72. Guardant Health Competitive Strengths & Weaknesses
Table 73. Neoimmune Basic Information, Manufacturing Base and Competitors
Table 74. Neoimmune Major Business
Table 75. Neoimmune Cancer Recurrence Monitoring Kit Product and Services
Table 76. Neoimmune Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Neoimmune Recent Developments/Updates
Table 78. Neoimmune Competitive Strengths & Weaknesses
Table 79. Labcorp Inc Basic Information, Manufacturing Base and Competitors
Table 80. Labcorp Inc Major Business
Table 81. Labcorp Inc Cancer Recurrence Monitoring Kit Product and Services
Table 82. Labcorp Inc Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Labcorp Inc Recent Developments/Updates
Table 84. Labcorp Inc Competitive Strengths & Weaknesses
Table 85. F.Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. F.Hoffmann-La Roche Ltd. Major Business
Table 87. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product and Services
Table 88. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. F.Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 90. F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 91. Cergentis B.V. Basic Information, Manufacturing Base and Competitors
Table 92. Cergentis B.V. Major Business
Table 93. Cergentis B.V. Cancer Recurrence Monitoring Kit Product and Services
Table 94. Cergentis B.V. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Cergentis B.V. Recent Developments/Updates
Table 96. Cergentis B.V. Competitive Strengths & Weaknesses
Table 97. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 98. Sysmex Corporation Major Business
Table 99. Sysmex Corporation Cancer Recurrence Monitoring Kit Product and Services
Table 100. Sysmex Corporation Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sysmex Corporation Recent Developments/Updates
Table 102. Sysmex Corporation Competitive Strengths & Weaknesses
Table 103. NeoGenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. NeoGenomics Laboratories, Inc. Major Business
Table 105. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 106. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. NeoGenomics Laboratories, Inc. Recent Developments/Updates
Table 108. NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
Table 109. Adaptive Basic Information, Manufacturing Base and Competitors
Table 110. Adaptive Major Business
Table 111. Adaptive Cancer Recurrence Monitoring Kit Product and Services
Table 112. Adaptive Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Adaptive Recent Developments/Updates
Table 114. Adaptive Competitive Strengths & Weaknesses
Table 115. Biotechnologies Corporation Basic Information, Manufacturing Base and Competitors
Table 116. Biotechnologies Corporation Major Business
Table 117. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product and Services
Table 118. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biotechnologies Corporation Recent Developments/Updates
Table 120. Biotechnologies Corporation Competitive Strengths & Weaknesses
Table 121. ArcherDX, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. ArcherDX, Inc. Major Business
Table 123. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 124. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. ArcherDX, Inc. Recent Developments/Updates
Table 126. ArcherDX, Inc. Competitive Strengths & Weaknesses
Table 127. Asuragen Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Asuragen Inc. Major Business
Table 129. Asuragen Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 130. Asuragen Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Asuragen Inc. Recent Developments/Updates
Table 132. Asuragen Inc. Competitive Strengths & Weaknesses
Table 133. Arup Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Arup Laboratories Inc. Major Business
Table 135. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 136. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Arup Laboratories Inc. Recent Developments/Updates
Table 138. Arup Laboratories Inc. Competitive Strengths & Weaknesses
Table 139. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Rad Laboratories Major Business
Table 141. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product and Services
Table 142. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bio-Rad Laboratories Recent Developments/Updates
Table 144. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 145. Opko Health Basic Information, Manufacturing Base and Competitors
Table 146. Opko Health Major Business
Table 147. Opko Health Cancer Recurrence Monitoring Kit Product and Services
Table 148. Opko Health Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Opko Health Recent Developments/Updates
Table 150. Opko Health Competitive Strengths & Weaknesses
Table 151. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 152. Quest Diagnostics Major Business
Table 153. Quest Diagnostics Cancer Recurrence Monitoring Kit Product and Services
Table 154. Quest Diagnostics Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Quest Diagnostics Recent Developments/Updates
Table 156. ICON plc Basic Information, Manufacturing Base and Competitors
Table 157. ICON plc Major Business
Table 158. ICON plc Cancer Recurrence Monitoring Kit Product and Services
Table 159. ICON plc Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Cancer Recurrence Monitoring Kit Upstream (Raw Materials)
Table 161. Cancer Recurrence Monitoring Kit Typical Customers
Table 162. Cancer Recurrence Monitoring Kit Typical Distributors
List of Figure
Figure 1. Cancer Recurrence Monitoring Kit Picture
Figure 2. World Cancer Recurrence Monitoring Kit Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Recurrence Monitoring Kit Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 5. World Cancer Recurrence Monitoring Kit Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2018-2029)
Figure 7. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2018-2029)
Figure 8. North America Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 9. Europe Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 10. China Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 11. Japan Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 12. Cancer Recurrence Monitoring Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 15. World Cancer Recurrence Monitoring Kit Consumption Market Share by Region (2018-2029)
Figure 16. United States Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 17. China Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 18. Europe Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 19. Japan Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 22. India Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cancer Recurrence Monitoring Kit by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cancer Recurrence Monitoring Kit Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cancer Recurrence Monitoring Kit Markets in 2022
Figure 26. United States VS China: Cancer Recurrence Monitoring Kit Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cancer Recurrence Monitoring Kit Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Recurrence Monitoring Kit Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 30. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 32. World Cancer Recurrence Monitoring Kit Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cancer Recurrence Monitoring Kit Production Value Market Share by Type in 2022
Figure 34. Blood Cancer
Figure 35. Bone Cancer
Figure 36. World Cancer Recurrence Monitoring Kit Production Market Share by Type (2018-2029)
Figure 37. World Cancer Recurrence Monitoring Kit Production Value Market Share by Type (2018-2029)
Figure 38. World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Cancer Recurrence Monitoring Kit Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Cancer Recurrence Monitoring Kit Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Cancer Recurrence Monitoring Kit Production Market Share by Application (2018-2029)
Figure 44. World Cancer Recurrence Monitoring Kit Production Value Market Share by Application (2018-2029)
Figure 45. World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Cancer Recurrence Monitoring Kit Industry Chain
Figure 47. Cancer Recurrence Monitoring Kit Procurement Model
Figure 48. Cancer Recurrence Monitoring Kit Sales Model
Figure 49. Cancer Recurrence Monitoring Kit Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Cancer Recurrence Monitoring Kit Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Cancer Recurrence Monitoring Kit Production Value by Region (2018-2023) & (USD Million)
Table 3. World Cancer Recurrence Monitoring Kit Production Value by Region (2024-2029) & (USD Million)
Table 4. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2018-2023)
Table 5. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2024-2029)
Table 6. World Cancer Recurrence Monitoring Kit Production by Region (2018-2023) & (K Units)
Table 7. World Cancer Recurrence Monitoring Kit Production by Region (2024-2029) & (K Units)
Table 8. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2018-2023)
Table 9. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2024-2029)
Table 10. World Cancer Recurrence Monitoring Kit Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Cancer Recurrence Monitoring Kit Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Cancer Recurrence Monitoring Kit Major Market Trends
Table 13. World Cancer Recurrence Monitoring Kit Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Cancer Recurrence Monitoring Kit Consumption by Region (2018-2023) & (K Units)
Table 15. World Cancer Recurrence Monitoring Kit Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Cancer Recurrence Monitoring Kit Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Cancer Recurrence Monitoring Kit Producers in 2022
Table 18. World Cancer Recurrence Monitoring Kit Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Cancer Recurrence Monitoring Kit Producers in 2022
Table 20. World Cancer Recurrence Monitoring Kit Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Cancer Recurrence Monitoring Kit Company Evaluation Quadrant
Table 22. World Cancer Recurrence Monitoring Kit Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Cancer Recurrence Monitoring Kit Production Site of Key Manufacturer
Table 24. Cancer Recurrence Monitoring Kit Market: Company Product Type Footprint
Table 25. Cancer Recurrence Monitoring Kit Market: Company Product Application Footprint
Table 26. Cancer Recurrence Monitoring Kit Competitive Factors
Table 27. Cancer Recurrence Monitoring Kit New Entrant and Capacity Expansion Plans
Table 28. Cancer Recurrence Monitoring Kit Mergers & Acquisitions Activity
Table 29. United States VS China Cancer Recurrence Monitoring Kit Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Cancer Recurrence Monitoring Kit Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Cancer Recurrence Monitoring Kit Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 37. China Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 42. Rest of World Based Cancer Recurrence Monitoring Kit Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share (2018-2023)
Table 47. World Cancer Recurrence Monitoring Kit Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Cancer Recurrence Monitoring Kit Production by Type (2018-2023) & (K Units)
Table 49. World Cancer Recurrence Monitoring Kit Production by Type (2024-2029) & (K Units)
Table 50. World Cancer Recurrence Monitoring Kit Production Value by Type (2018-2023) & (USD Million)
Table 51. World Cancer Recurrence Monitoring Kit Production Value by Type (2024-2029) & (USD Million)
Table 52. World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Cancer Recurrence Monitoring Kit Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Cancer Recurrence Monitoring Kit Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Cancer Recurrence Monitoring Kit Production by Application (2018-2023) & (K Units)
Table 56. World Cancer Recurrence Monitoring Kit Production by Application (2024-2029) & (K Units)
Table 57. World Cancer Recurrence Monitoring Kit Production Value by Application (2018-2023) & (USD Million)
Table 58. World Cancer Recurrence Monitoring Kit Production Value by Application (2024-2029) & (USD Million)
Table 59. World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Cancer Recurrence Monitoring Kit Average Price by Application (2024-2029) & (US$/Unit)
Table 61. SeekIn Basic Information, Manufacturing Base and Competitors
Table 62. SeekIn Major Business
Table 63. SeekIn Cancer Recurrence Monitoring Kit Product and Services
Table 64. SeekIn Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. SeekIn Recent Developments/Updates
Table 66. SeekIn Competitive Strengths & Weaknesses
Table 67. Guardant Health Basic Information, Manufacturing Base and Competitors
Table 68. Guardant Health Major Business
Table 69. Guardant Health Cancer Recurrence Monitoring Kit Product and Services
Table 70. Guardant Health Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Guardant Health Recent Developments/Updates
Table 72. Guardant Health Competitive Strengths & Weaknesses
Table 73. Neoimmune Basic Information, Manufacturing Base and Competitors
Table 74. Neoimmune Major Business
Table 75. Neoimmune Cancer Recurrence Monitoring Kit Product and Services
Table 76. Neoimmune Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Neoimmune Recent Developments/Updates
Table 78. Neoimmune Competitive Strengths & Weaknesses
Table 79. Labcorp Inc Basic Information, Manufacturing Base and Competitors
Table 80. Labcorp Inc Major Business
Table 81. Labcorp Inc Cancer Recurrence Monitoring Kit Product and Services
Table 82. Labcorp Inc Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Labcorp Inc Recent Developments/Updates
Table 84. Labcorp Inc Competitive Strengths & Weaknesses
Table 85. F.Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. F.Hoffmann-La Roche Ltd. Major Business
Table 87. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Product and Services
Table 88. F.Hoffmann-La Roche Ltd. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. F.Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 90. F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 91. Cergentis B.V. Basic Information, Manufacturing Base and Competitors
Table 92. Cergentis B.V. Major Business
Table 93. Cergentis B.V. Cancer Recurrence Monitoring Kit Product and Services
Table 94. Cergentis B.V. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Cergentis B.V. Recent Developments/Updates
Table 96. Cergentis B.V. Competitive Strengths & Weaknesses
Table 97. Sysmex Corporation Basic Information, Manufacturing Base and Competitors
Table 98. Sysmex Corporation Major Business
Table 99. Sysmex Corporation Cancer Recurrence Monitoring Kit Product and Services
Table 100. Sysmex Corporation Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Sysmex Corporation Recent Developments/Updates
Table 102. Sysmex Corporation Competitive Strengths & Weaknesses
Table 103. NeoGenomics Laboratories, Inc. Basic Information, Manufacturing Base and Competitors
Table 104. NeoGenomics Laboratories, Inc. Major Business
Table 105. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 106. NeoGenomics Laboratories, Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. NeoGenomics Laboratories, Inc. Recent Developments/Updates
Table 108. NeoGenomics Laboratories, Inc. Competitive Strengths & Weaknesses
Table 109. Adaptive Basic Information, Manufacturing Base and Competitors
Table 110. Adaptive Major Business
Table 111. Adaptive Cancer Recurrence Monitoring Kit Product and Services
Table 112. Adaptive Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Adaptive Recent Developments/Updates
Table 114. Adaptive Competitive Strengths & Weaknesses
Table 115. Biotechnologies Corporation Basic Information, Manufacturing Base and Competitors
Table 116. Biotechnologies Corporation Major Business
Table 117. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Product and Services
Table 118. Biotechnologies Corporation Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Biotechnologies Corporation Recent Developments/Updates
Table 120. Biotechnologies Corporation Competitive Strengths & Weaknesses
Table 121. ArcherDX, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. ArcherDX, Inc. Major Business
Table 123. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 124. ArcherDX, Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. ArcherDX, Inc. Recent Developments/Updates
Table 126. ArcherDX, Inc. Competitive Strengths & Weaknesses
Table 127. Asuragen Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Asuragen Inc. Major Business
Table 129. Asuragen Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 130. Asuragen Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Asuragen Inc. Recent Developments/Updates
Table 132. Asuragen Inc. Competitive Strengths & Weaknesses
Table 133. Arup Laboratories Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Arup Laboratories Inc. Major Business
Table 135. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Product and Services
Table 136. Arup Laboratories Inc. Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Arup Laboratories Inc. Recent Developments/Updates
Table 138. Arup Laboratories Inc. Competitive Strengths & Weaknesses
Table 139. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 140. Bio-Rad Laboratories Major Business
Table 141. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Product and Services
Table 142. Bio-Rad Laboratories Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Bio-Rad Laboratories Recent Developments/Updates
Table 144. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 145. Opko Health Basic Information, Manufacturing Base and Competitors
Table 146. Opko Health Major Business
Table 147. Opko Health Cancer Recurrence Monitoring Kit Product and Services
Table 148. Opko Health Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Opko Health Recent Developments/Updates
Table 150. Opko Health Competitive Strengths & Weaknesses
Table 151. Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table 152. Quest Diagnostics Major Business
Table 153. Quest Diagnostics Cancer Recurrence Monitoring Kit Product and Services
Table 154. Quest Diagnostics Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Quest Diagnostics Recent Developments/Updates
Table 156. ICON plc Basic Information, Manufacturing Base and Competitors
Table 157. ICON plc Major Business
Table 158. ICON plc Cancer Recurrence Monitoring Kit Product and Services
Table 159. ICON plc Cancer Recurrence Monitoring Kit Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 160. Global Key Players of Cancer Recurrence Monitoring Kit Upstream (Raw Materials)
Table 161. Cancer Recurrence Monitoring Kit Typical Customers
Table 162. Cancer Recurrence Monitoring Kit Typical Distributors
List of Figure
Figure 1. Cancer Recurrence Monitoring Kit Picture
Figure 2. World Cancer Recurrence Monitoring Kit Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cancer Recurrence Monitoring Kit Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 5. World Cancer Recurrence Monitoring Kit Average Price (2018-2029) & (US$/Unit)
Figure 6. World Cancer Recurrence Monitoring Kit Production Value Market Share by Region (2018-2029)
Figure 7. World Cancer Recurrence Monitoring Kit Production Market Share by Region (2018-2029)
Figure 8. North America Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 9. Europe Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 10. China Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 11. Japan Cancer Recurrence Monitoring Kit Production (2018-2029) & (K Units)
Figure 12. Cancer Recurrence Monitoring Kit Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 15. World Cancer Recurrence Monitoring Kit Consumption Market Share by Region (2018-2029)
Figure 16. United States Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 17. China Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 18. Europe Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 19. Japan Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 20. South Korea Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 22. India Cancer Recurrence Monitoring Kit Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Cancer Recurrence Monitoring Kit by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cancer Recurrence Monitoring Kit Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cancer Recurrence Monitoring Kit Markets in 2022
Figure 26. United States VS China: Cancer Recurrence Monitoring Kit Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Cancer Recurrence Monitoring Kit Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cancer Recurrence Monitoring Kit Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 30. China Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Cancer Recurrence Monitoring Kit Production Market Share 2022
Figure 32. World Cancer Recurrence Monitoring Kit Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Cancer Recurrence Monitoring Kit Production Value Market Share by Type in 2022
Figure 34. Blood Cancer
Figure 35. Bone Cancer
Figure 36. World Cancer Recurrence Monitoring Kit Production Market Share by Type (2018-2029)
Figure 37. World Cancer Recurrence Monitoring Kit Production Value Market Share by Type (2018-2029)
Figure 38. World Cancer Recurrence Monitoring Kit Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Cancer Recurrence Monitoring Kit Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Cancer Recurrence Monitoring Kit Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Cancer Recurrence Monitoring Kit Production Market Share by Application (2018-2029)
Figure 44. World Cancer Recurrence Monitoring Kit Production Value Market Share by Application (2018-2029)
Figure 45. World Cancer Recurrence Monitoring Kit Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Cancer Recurrence Monitoring Kit Industry Chain
Figure 47. Cancer Recurrence Monitoring Kit Procurement Model
Figure 48. Cancer Recurrence Monitoring Kit Sales Model
Figure 49. Cancer Recurrence Monitoring Kit Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
